Alcohol Use & Sexual Risk: An Intervention

Status Withdrawn

Clinical Trial Summary

Adolescents are at great risk for sexually transmitted diseases (STDs) including the human immunodeficiency virus (HIV) (CDC, 2000a; DiLorenzo & Whaley, 1999). Though the CDC (2000b) reports that overall AIDS incidence is on the decline, there has been no comparable decline in the number of newly diagnosed HIV cases among young people aged 13-19, and young people of color are particularly at risk. Compared to the general adolescent population, adolescents involved with the criminal justice system are younger at first intercourse, have a greater number of sex partners, and lower rates of condom use, resulting in higher rates of unintended pregnancy and STDs (e.g., St. Lawrence et al., 1999). Alcohol use is commonly cited as a reason for lack of condom use among high-risk adolescents such as those involved in the criminal justice system (e.g., Morris et al., 1998) and recent data from our research suggests that it is heavy alcohol use in concert with sexual activity that is most strongly related to lack of condom use (Bryan, Rocheleau, & Robbins, 2002a). The goal of this research is to design, implement, evaluation, and disseminate a successful HIV/STD risk reduction intervention that is theory-based, empirically targeted to adolescents, and articulated to a criminal justice setting. The study compares a sexual risk reduction intervention with a group motivational interviewing alcohol component to a standard sexual risk reduction intervention and a no treatment control condition. The investigators hope to show that: 1) A three-hour one-time intervention has the capacity to reduce sexual risk behavior up to one year post-release among high risk adolescents in detention, 2) A combined sexual and alcohol risk reduction intervention will result in larger decreases in sexual risk behavior than a sexual risk reduction alone, 3) The interventions will exert their effects through changes in mediators derived from a theoretically-based model of condom use intentions and behaviors, and 4) A sexual risk reduction intervention including an alcohol component will be especially effective for those adolescents with higher levels of existing alcohol problems. Finally, given proven efficacy, the intervention curricula and materials will be disseminated for use in adolescent detention facilities throughout the state.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00914719
Study type	Interventional
Source	University of New Mexico
Contact
Status	Withdrawn
Phase	N/A
Start date	September 2002
Completion date	September 2002

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05468879` - Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects	N/A
Completed	`NCT02293057` - Gender-Responsive Drug Use Treatment for Juvenile Justice Girls	N/A
Completed	`NCT01941108` - Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care	N/A
Completed	`NCT01380613` - Neighborhoods, Networks, Depression, and HIV Risk	Phase 2
Recruiting	`NCT03671629` - Pharmacist Intervention to Reduce Drug-related Readmissions Among the Elderly	N/A
Completed	`NCT03290391` - Linking Infectious and Narcology Care-Part II	Phase 4
Completed	`NCT04008927` - A Community-based Intervention Among Active Drug Users in Montpellier	N/A
Completed	`NCT03627546` - HCV Seek, Test and Rapid Treatment for Young PWID	N/A
Recruiting	`NCT05380765` - Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents	N/A
Not yet recruiting	`NCT03967262` - Secondary Prevention and Recidivism Reduction in Trauma Patients	N/A
Completed	`NCT03079856` - Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER	N/A
Completed	`NCT03855410` - Preventing Cigarette Use Among Urban Youth Via an M-Health Primary Care Preventive Intervention	N/A
Terminated	`NCT02457949` - The Impact of Alternative Social Assistance Disbursement on Drug-related Harm	N/A
Completed	`NCT06238154` - Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds	Phase 4
Terminated	`NCT04436055` - Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)
Recruiting	`NCT04717856` - Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA	N/A
Completed	`NCT00249496` - Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1	N/A
Recruiting	`NCT05597865` - Assessing the Feasibility of Economic Approaches to Prevent Substance Abuse Among Adolescents	N/A
Completed	`NCT05553054` - Drug Wastage : Observational Study in Intensive Care Units in France
Completed	`NCT03718520` - The Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural Connectivity

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Alcohol Use and Sexual Risk: An Intervention

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms